Press Release: Who are the originators of innovative medicines in the EU?

Author (Corporate)
Series Title
Series Details 31.01.14
Publication Date 31/01/2014
Content Type

Over 40% of innovative medicines recommended for marketing authorisation in the European Union (EU) between 2010 and 2012 originated from small or medium-sized enterprises (SMEs), academia, public bodies and public-private partnerships.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2014/01/news_detail_002015.jsp&mid=WC0b01ac058004d5c1
Related Links
Nature Reviews Drug Discovery: Regulatory watch: Where do new medicines originate from in the EU? [2014] http://dx.doi.org/10.1038/nrd4232
Subject Categories ,
Countries / Regions